Cardinal Health Inc (CAH)
Official siteHEALTHCARE • MEDICAL DISTRIBUTION • NYSE
Market Cap: $64.97B
Last updated: Nov 17, 2026 at 11:05 AM ET
Cardinal Health Inc (CAH) Stock Forecast
Analysts expect Cardinal Health (CAH) to earn $13.00 per share in the fiscal year ending Jun 30, 2027, on revenue of $266.13B. Of 17 analysts, 14 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Jun 30, 2027 was revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 17 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 82% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 17.6% |
| Buy | 11 | 64.7% |
| Hold | 3 | 17.6% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 17
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 10.2% and revenue estimates rise 6.1%.
- Fiscal year ending Jun 30, 2027
- $13.00
- EPS consensus, revenue $266.13B
- Fiscal year ending Jun 30, 2028
- $14.33
- EPS consensus, revenue $282.43B
- Next report
- Feb 3, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Jun 30, 2027 | $13.00 | $12.93 to $13.16 | 12 | $266.13B | $264.43B to $268.32B | 15 |
| Jun 30, 2028 | $14.33 | $13.26 to $15.15 | 17 | $282.43B | $274.92B to $292.99B | 14 |
Quarterly Estimates
Across the 3 quarters below, the EPS consensus is lowest for the quarter ending Dec 31, 2026, at $3.13, and highest for the quarter ending Mar 31, 2027, at $3.36.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $3.13 | $2.93 to $3.64 | 10 | $68.36B | $67.48B to $69.22B | 10 |
| Mar 31, 2027 | $3.36 | $2.91 to $3.51 | 10 | $63.63B | $61.92B to $64.34B | 10 |
| Jun 30, 2027 | $3.22 | $2.96 to $3.77 | 17 | $67.36B | $64.66B to $70.90B | 13 |
Estimate Revisions
Across the 4 periods below, the last 30 days brought 7 upward and 6 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Jun 30, 2027 | 1 | 1 |
| Fiscal year ending Jun 30, 2028 | 3 | 1 |
| Quarter ending Dec 31, 2026 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 2 | 4 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Jun 30, 2027 has risen 4.1% from $12.49.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Jun 30, 2027 | $13.00 | $12.56 | $12.56 | $12.57 | $12.49 | +4.1% |
| Fiscal year ending Jun 30, 2028 | $14.33 | $14.06 | $14.06 | $14.08 | $13.90 | +3.1% |
| Quarter ending Dec 31, 2026 | $3.13 | $3.13 | $3.12 | $3.11 | $3.07 | +1.9% |
| Quarter ending Mar 31, 2027 | $3.36 | $3.36 | $3.36 | $3.37 | $3.45 | -2.5% |
Frequently Asked Questions About CAH
What is the CAH stock forecast?
Consensus analyst estimates put Cardinal Health's EPS at $13.00 for the fiscal year ending Jun 30, 2027, on revenue of $266.13B. The consensus rating from 17 analysts is Buy.
How do analysts rate CAH stock?
Of 17 analysts covering Cardinal Health, 3 rate it Strong Buy, 11 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from CAH next year?
For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is $13.00, with estimates from $12.93 to $13.16 from 12 analysts. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is $14.33, with estimates from $13.26 to $15.15 from 17 analysts.
What revenue do analysts expect from Cardinal Health next year?
For the fiscal year ending Jun 30, 2027, the consensus revenue estimate is $266.13B, with estimates from $264.43B to $268.32B. For the fiscal year ending Jun 30, 2028, the consensus revenue estimate is $282.43B, with estimates from $274.92B to $292.99B.
How many analysts cover CAH?
17 analysts rate Cardinal Health stock, and 12 analysts estimate its EPS for the fiscal year ending Jun 30, 2027.
CAH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts